Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VEGZELMA DIN 02534185

Status: Marketed
Holder: CELLTRION INC.
Molecule: BEVACIZUMAB

Health Canada record

Active ingredient(s)BEVACIZUMAB 400 MG
Dosage formSolution
RouteIntravenous
ScheduleSCHEDULE D; PRESCRIPTION
ClassHuman
ATCL01FG01 BEVACIZUMAB
Original market date01-May-2023
Current status date28-Mar-2024
SourceHealth Canada DPD

Establishment licence of the holder

Celltrion Healthcare Canada Limited — licence 3-002622, currently licensed, last inspection rating C (2025-11-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BEVACIZUMAB

DINProductCompanyFormStrengthStatus
02522160ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 400 MGMarketed
02522179ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 100 MGMarketed
02270994AVASTINHOFFMANN-LA ROCHE LIMITEDSolutionBEVACIZUMAB 25 MGMarketed
02522829AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 100 MGMarketed
02522837AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 400 MGMarketed
02520729BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 100 MGMarketed
02520737BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 400 MGMarketed
02567865BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 400 MGApproved
02567830BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 100 MGApproved
02470748MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02470756MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02534177VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 100 MGMarketed
02489430ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 100 MGMarketed
02489449ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 400 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
329812024-03-28New Drug Submission (NDS)Administrative - Merger/Buy-out
298202023-01-03New Drug Submission (NDS)
Request a quote for VEGZELMA

How to read a Canadian DIN record